JPT Peptide Technologies is the acknowledged supplier of innovative peptide based products and services for the development of novel immunotherapies and diagnostics. JPT's core technologies Spot and PepStar™ peptide arrays; PepMix™ peptide pools; PepTrack™ peptide libraries as well as its premium synthesis unit provide essential reagents and services for vaccine development, biomarker discovery, and immune monitoring. With SpikeTides™ - development of high-thoughput SRM/MRM assays for protein quantification becomes a cost efficient endeavour for the first time.
Employing these proprietary technologies in state-of-the-art facilities, it is our ambition to enable:
- High-throughput T-cell epitope discovery (PepTrack™ Peptide Libraries)
- Proteome wide seromarker discovery and monitoring of humoral immune responses (PepStar™ peptide microarrays)
- Antibody epitope mapping (PepSpot™ peptide membranes)
- In vitro profiling of neutralizing antibody action (RepliTope™ peptide microarrays)
- Vaccine efficacy testing, immune monitoring and adoptive immunotherapy research (PepMix™ - antigen spanning and mixed epitope peptide pools)
- Development of peptide based vaccines and synthesis of peptide standards for validation of T-cell assays (Custom Peptide Synthesis)
- Development of high-thoughput SRM/MTM assays and quantification of protein expression levels (SpikeTides™)
Innovation, quality, turn-around time and price of our products and services combined with the expertise and experience, and the responsiveness of our service make us a unique partner for your research in Immunology and proteomics.
News
Visit us at the:
HUPO 2010
Sep.19-23, 2010
Sydney, Australia
=> read more
JPT's high density peptide microarrays at work:
"Long-Lived Plasma Cells and Memory B Cells Produce Pathogenic Anti-GAD65 Autoantibodies in Stiff Person Syndrome"
Rizzi et al.=> read more

